Minerva Neurosciences, Inc.NERVNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -112.18% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -112.19% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -112.12% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -112.12% | +0.00% |
| Weighted Average Shares Growth | +0.00% | +0.00% | -0.00% | +0.00% | +46.89% |
| Weighted Average Shares Diluted Growth | +0.00% | +0.00% | -0.00% | +0.00% | +46.89% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -34.72% | -35.07% | -34.29% | -34.38% | +163.76% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +0.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| R&D Expense Growth | -58.00% | -67.31% | -66.38% | -50.98% | +9.64% |
| SG&A Expenses Growth | +3.59% | +1.02% | -14.11% | -22.64% | +10.58% |